Could Immunomedics, Inc.(NASDAQ:IMMU), Can Fite Biopharma Ltd (ADR)(NYSEMKT:CANF), and SSE PLC(ADR)(OTCMKTS:SSEZY)Prove To Be Savvy Investments?
New York, NY – GDP INSIDER – 11/27/2014.
This article discusses three companies: Immunomedics, Inc.(NASDAQ:IMMU), Can Fite Biopharma Ltd (ADR)(NYSEMKT:CANF), and SSE PLC(ADR)(OTCMKTS:SSEZY)
Immunomedics, Inc.(NASDAQ:IMMU)announced on Nov. 21st that its Veltuzumab drug, which would be used in the treatment of Pemphigus, had received an orphan drug designation. The company has a one year target estimate of $7.67 and finished yesterday’s trading at a closing price of $4.12 after a thirteen cent gain. Now may be the time for investors to jump onto the Immunomedics bandwagon, as the stock also had a high trading volume yesterday.
Can Fite Biopharma Ltd (ADR)(NYSEMKT:CANF)is an Israel-based clinical-stage biotechnology company that is involved in the development of small molecule therapeutic products. H.C. Wainwright initiated coverage of the stock on Nov. 18th, assigning a “Buy” rating. The company, which has a market capitalization of $37.68 million, had a trading volume of 0.84 million yesterday. This figure, which is 0.51 million higher than Can Fite Biopharma’s three month average volume of 0.33 million, suggests that investor interest in the stock is rising rapidly.
SSE PLC(ADR)(OTCMKTS:SSEZY)is involved in the generation, transmission, distribution, and supplying of electricity in the United Kingdom and Ireland. The company’s electricity sources include renewable sources like water and wind, as well as more traditional sources like gas, oil, and coal. The company has a price to earnings ratio (ttm) of $78.95 and an earnings per share (ttm) of $0.32. SSE PLC’s trading price of $25.50 is $0.42 higher than its one year target estimate of $25.08.
HotStockGains.com provides investors and traders with trading strategies via text message and email. To obtain text message stock alerts service text the word BREAKOUT to 555888 from your cell phone.
Additionally, HotStockGains free newsletter provides market insight, tips, and trading strategies on NYSE, NASDAQ, OTCBB and PINK stocks.
Disclosure: HotStockGains is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Always seek help from a professional financial advisor (I am not one). Please visit http://hotstockgains.com/disclaimer/ for complete risks and disclosures.